14-day Premium Trial Subscription Try For FreeTry Free
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Price (Quote)

New York Stock Exchange
Open Broker Account
$0.130
+0 (+0%)
At Close: Jan 16, 2018
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 16th Jan 2018 MSTX stock ended at $0.130. During the day the stock fluctuated 0% from a day low at $0.130 to a day high of $0.130.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Mast Therapeutics, Inc prices

Date Open High Low Close Volume
Mar 24, 2017 $0.119 $0.124 $0.108 $0.114 6 324 318
Mar 23, 2017 $0.101 $0.110 $0.100 $0.107 5 153 867
Mar 22, 2017 $0.102 $0.105 $0.0980 $0.0980 2 679 712
Mar 21, 2017 $0.102 $0.110 $0.100 $0.102 3 449 646
Mar 20, 2017 $0.104 $0.106 $0.0960 $0.102 2 733 329
Mar 17, 2017 $0.105 $0.106 $0.0980 $0.101 4 642 387
Mar 16, 2017 $0.110 $0.110 $0.100 $0.105 4 026 626
Mar 15, 2017 $0.110 $0.111 $0.102 $0.103 3 625 797
Mar 14, 2017 $0.110 $0.111 $0.104 $0.107 4 115 084
Mar 13, 2017 $0.114 $0.115 $0.109 $0.111 3 100 200
Mar 10, 2017 $0.116 $0.118 $0.112 $0.114 2 895 977
Mar 09, 2017 $0.113 $0.114 $0.110 $0.112 2 672 473
Mar 08, 2017 $0.112 $0.116 $0.110 $0.112 2 383 817
Mar 07, 2017 $0.121 $0.121 $0.108 $0.112 3 811 798
Mar 06, 2017 $0.120 $0.124 $0.116 $0.119 5 858 573
Mar 03, 2017 $0.116 $0.118 $0.110 $0.113 3 417 771
Mar 02, 2017 $0.117 $0.125 $0.115 $0.119 4 448 388
Mar 01, 2017 $0.111 $0.120 $0.106 $0.118 6 357 182
Feb 28, 2017 $0.117 $0.119 $0.110 $0.111 3 267 256
Feb 27, 2017 $0.120 $0.122 $0.115 $0.118 3 006 893
Feb 24, 2017 $0.120 $0.120 $0.120 $0.120 4 943 474
Feb 23, 2017 $0.130 $0.130 $0.122 $0.123 4 177 532
Feb 22, 2017 $0.131 $0.131 $0.125 $0.125 2 918 473
Feb 21, 2017 $0.134 $0.134 $0.126 $0.127 5 645 775
Feb 17, 2017 $0.130 $0.132 $0.125 $0.130 4 108 972
Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Golden Star

Ticker Date Change Price
BBCA May 03 1.26% $65.44
ADTH May 03 5.56% $3.24
ISTB May 03 0.0425% $47.11
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
INVH May 03 1.72% $34.39
INTU May 03 1.89% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT